Category Archives: Public View

All pages are restricted to logged in viewers except those with Category “Public View”

D.C. Update – July 24, 2015

News from NASADAD

  • NASADAD delivers President’s Award to Bob Glover, Executive Director of National Association of State Mental Health Program Directors (NASMHPD)
  • NASADAD attends Capitol Hill briefing on benefits of prevention
  • NASADAD attends Capitol Hill briefing on hepatitis prevention and treatment
  • NASADAD attends Capitol Hill briefing on criminal justice reform

Around the Agencies

  • New GAO study finds 17 percent of low-income, uninsured adults have mental health or substance use disorders
  • Carlos Blanco appointed to lead NIDA’s Division of Epidemiology, Services, and Prevention Research

In the News

  • NAMSDL releases new reports on medicinal and legal marijuana legislation
  • Washington, D.C. plans new campaign to fight underage drinking
  • Faces & Voices of Recovery announce the addition of H. Westley Clark, Jan Brown, Stacia Murphy, and Sis Wenger to Board of Directors
  • House Energy and Commerce Committee approves PDMP authorization bill with language to help promote collaboration with State substance abuse agencies
  • House Energy and Commerce Subcommittee Committee considers and approves H.R. 1462, the Protecting Our Infants Act

News from NASADAD

NASADAD delivers President’s Award to Bob Glover, Executive Director of National Association of State Mental Health Program Directors (NASMHPD)
On Friday, July 17, NASADAD Executive Director Robert Morrison (pictured on the right) presented Bob Glover (left) with an award for his decades of service to State Mental Health Authorities in particular, and the public mental health service system in general, as Executive Director of NASMHPD. Dr. Glover has served NASMHPD as Executive Director since 1993. In addition, Dr. Glover led State mental health service delivery systems in States such as Maine, Colorado, Ohio, and Pennsylvania. Mark Stringer, State Director of Missouri and past-President of NASADAD, chose to honor Glover before stepping aside as Board Chair in June 2015. The award was announced during NASADAD’s Annual Meeting held in Charleston, South Carolina. After presenting the award, Robert Morrison then met with Dr. Glover and Brian Hepburn, MD, the new Executive Director of NASMHPD, to share priorities and talk about continued collaboration of the two Associations.

NASADAD attends Capitol Hill briefing on benefits of prevention
On Thursday, July 16, Robert Morrison, Executive Director attended a Capitol Hill briefing sponsored by the National Coalition on Health Care (NCHC) titled “Bending the Health Care Cost Curve: The Role of Investments in Prevention.” The speakers included David Dobbins, Chief Operating Officer, the Legacy Institute; Rich Hamburg, Deputy Director, Trust for America’s Health (TFAH); and Chris Hansen, President, American Cancer Society’s Cancer Action Network. The speakers outlined issues from their organizations’ particular perspectives with an emphasis on prevention and cancer in particular. Rich Hamburg of TFAH discussed recent actions taken by his organization, including an initiative that examines obesity in the United States. As many NASADAD members recall, TFAH has dedicated many resources to addressing the opioid issue as well. For example, in 2013, TFAH issued Prescription Drug Abuse: Strategies to Stop the Epidemic that included a number of NASADAD-supported recommendations – including the benefits of investing in substance use disorder treatment, prevention, and recovery services.

To learn more about the Legacy Institute, click here.

To learn more about the Cancer Action Network, click here.

To learn more about the Trust for America’s Health (TFAH), click here.

To learn more about the National Coalition on Health Care (NCHC), click here.

NASADAD attends Capitol Hill briefing on hepatitis prevention and treatment
On Tuesday, July 21, Brian Denten, Public Policy Intern, attended a Congressional briefing on hepatitis prevention and treatment hosted by the Hepatitis Foundation International. The briefing focused on the prevalence of hepatitis throughout the United States and the disparities in diagnosis and treatment within minority populations. Hepatitis currently affects more than 5.3 million Americans, yet 3 in 4 with viral hepatitis do not know they are infected. Viral hepatitis and its variations disproportionately affect African-American, Latino, and Asian-American communities compared to the general population; with 3 percent of African-Americans and 2.6 percent of Latinos having hepatitis C compared to the national average of 1.5 percent, and Asian-Americans accounting for more than half of the country’s chronic hepatitis B population despite making up less than 5 percent of the total U.S. population.

The briefing heard from several advocates representing each minority group, reinforcing the need for a comprehensive strategy for reducing the spread of hepatitis among minority populations. From 2010-2013, diagnoses of acute hepatitis C rose over 150% as a result of injection drug use among white and adolescent populations. The Centers for Disease Control and Prevention (CDC) is currently developing two projects to address the rise of hepatitis C among this group. Pending legislation such as The Viral Hepatitis Testing Act would authorize more than $80 million over three years to “create the first comprehensive national system to combat viral hepatitis, in addition to enhancing and strengthening surveillance, education, testing, and linkage to care for at-risk Americans.”

Speakers:

  • Representative Brett Guthrie (R-KY)
  • Ivonne Fuller Cameron; CEO, Hepatitis Foundation International
  • John Ward; Director of Hepatitis, CDC
  • J. Nadine Garcia; Director of Minority Health, HHS
  • Nicole Smith; Associate Director, Division of Viral Hepatitis, CDC
  • Rui Grabowski; HFI North Carolina Patient Ambassador
  • Mollie B. Jackson-Woodson; HFI Maryland Patient Ambassador

To learn more about activities moving forward on Hep C by our sister Association, the National Alliance of State and Territorial AIDS Directors, visit here.

NASADAD attends Capitol Hill briefing on criminal justice reform

The briefing, held on Thursday, July 23, was attended by Brian Denten, Public Policy Intern. The briefing was hosted by the American Conservative Foundation, the American Coalition for Criminal Justice Reform, and Families Against Mandatory Minimums. Several speakers and formerly incarcerated individuals spoke about the need for broad structural reform of mandatory minimum sentencing laws and the creation of programs within prisons to reduce recidivism. Representative Jim Sensenbrenner (R-WI) opened the briefing with a discussion of how the federal prison population has risen substantially in recent decades despite an overall decrease in crime rates. Rep. Sensenbrenner stated that the current criminal justice system lacks the ability to rehabilitate non-violent offenders, leading to high rates of recidivism throughout the country.

Speakers:

  • Representative F. James Sensenbrenner, Jr.
  • David Keene; Opinion Editor, Washington Times
  • Pat Nolan; Director, Center for Criminal Justice Reform, American Conservative Union Foundation
  • Bernard Kerik; Director and Founder, American Coalition for Criminal Justice Reform
  • Kevin Ring; Director of Strategic Initiatives, Families Against Mandatory Minimums
  • Moderator: Molly Gill; Government Affairs Counsel, Families Against Mandatory Minimums

Around the Agencies

New GAO study finds 17 percent of low-income, uninsured adults have mental health or substance use disorders
The U.S. Government Accountability Office (GAO) released a new report this week examining the prevalence of mental health and substance use disorders among low-income and uninsured adults. Using data from 2008-2013, the study found that “approximately 17 percent of low-income, uninsured adults (3 million) had a behavioral health condition, defined as a serious mental illness, a substance use condition, or both.” The GAO notes that the frequency of each respective condition varies substantially at the State level – with Indiana, Wisconsin, Idaho, Ohio, and North Dakota having the highest rates of serious mental illness, and Rhode Island, Alaska, Ohio, Indiana, and North Dakota having the highest rates of substance use disorders among the low-income, uninsured adult population.

Carlos Blanco appointed to lead NIDA’s Division of Epidemiology, Services, and Prevention Research
Carlos Blanco, M.D., Ph.D., has been appointed to lead the National Institute on Drug Abuse’s (NIDA) Division of Epidemiology, Services, and Prevention Research. This division concentrates on improving public health through the support of research investigating the patterns and effects of substance use disorders, in addition to advocating for evidence-based treatment practices. Dr. Blanco currently works as a professor of psychiatry at Columbia University Medical Center, and is nationally recognized as an expert in treating co-occurring substance use and mental health disorders. His past notable research accomplishments include an extensive examination of the different stages of substance use disorders, the development of research methods to improve clinical trials, and the testing of various evidence-based treatment theories. Dr. Blanco’s research recently found that individuals in recovery from a substance use disorder are not at increased risk of developing a new substance use disorder for a different drug.

In the News

NAMSDL releases new reports on medicinal and legal marijuana legislation
The National Alliance for Model State Drug Laws (NAMSDL) released a series of new reports on medicinal, legal, and illegal marijuana legislation. The reports summarize ongoing and future efforts to regulate both the medical marijuana and legal marijuana industries at the State level. Four reports are available, summarizing legislation dealing with: medicinal use of marijuana (including low-THC / high cannabinoid products), “follow-up” legislation in States that have legalized the personal usage of marijuana (Alaska, Colorado, D.C., Oregon, and Washington), the usage of marijuana in States with ongoing legalization efforts, and legislative efforts to decriminalize or lower penalties for illicit, personal non-medical use.

Washington, D.C. plans new campaign to fight underage drinking
Washington D.C. Mayor Muriel Bowser announced a new campaign to fight underage drinking this past week. The campaign, titled “There’s a Reason,” will be coordinated by the D.C. Department of Behavioral Health using federally provided funding. A 2012 D.C. Department of Health study examining underage drinking found that nearly a quarter of D.C. youth consume alcohol before age 13, and that 6 percent of boys 11 or younger have tried alcohol. The survey also found that alcohol is more commonly used within D.C.’s middle schools than marijuana and other illicit substances; with approximately 31 percent of adolescents entering high school stating they drank an alcoholic beverage in the past month.  The campaign plans to target parents through educational pamphlets and additional outreach activities, and will primarily focus on people under the age of 18 rather than D.C.’s large college student population.

Faces & Voices of Recovery announce the addition of H. Westley Clark, Jan Brown, Stacia Murphy, and Sis Wenger to Board of Directors

Faces & Voices of Recovery (FAVOR) has announced the addition of four new members to the foundation’s Board of Directors: H. Westley Clark, Jan Brown, Stacia Murphy, and Sis Wenger.

  • Westley Clark, M.D., J.D., M.P.H., CAS, FASAM: Dr. Clark currently serves as the Dean’s Executive Professor of Public Health at Santa Clara University in Santa Clara, California. Dr. Clark formerly served as the Director of the Center for Substance Abuse Treatment (CSAT) at the Substance Abuse and Mental Health Services Administration (SAMHSA) where he focused on expanding access to treatment for Americans with substance use disorders. Dr. Clark has also served as the former chief of the Associated Substance Abuse Programs at the U.S. Department of Veterans Affairs Medical Center in San Francisco, California; as senior program consultant to the Robert Wood Johnson Foundation Substance Abuse Policy Program; and as co-investigator on several National Institute on Drug Abuse (NIDA) research grants.
  • Jan Brown: Jan Brown currently works as the Founding/Executive Director of Spiritworks Foundation Center for Recovery of the Soul located in Williamsburg, Virginia. Ms. Brown is in long-term recovery from her own substance use disorder, and is certified as a Recovery Support Specialist in addition to being one of four people in the country certified as a Master Recovery Life Coach. Ms. Brown was recently appointed to the Governor of Virginia’s Task Force on Prescription Drug and Heroin Abuse.
  • Stacia Murphy: Stacia Murphy previously served as the appointed President of the National Council on Alcoholism and Drug Dependence (NCADD) from September 1999 to January 2006. Prior to working with NCADD, Ms. Murphy gained considerable experience working as a community organizer with young adults and adolescents in East and West Harlem and Brooklyn, New York. Additionally, Ms. Murphy worked as a member of the National Institute on Alcoholism and Alcohol Abuse from 2000 to 2006 and as a member of the steering community work group at SAMSHA.
  • Sis Wenger: Sis Wenger has worked as the President and CEO of the National Association for Children of Alcoholics (NACoA) for the last 21 years. At NACoA, Ms. Wenger has worked as an advocate and researcher for policy issues related to alcohol use disorders. Ms. Wenger previously served as the lead developer of SAMHSA’s Children’s Program Kit – a tool created for school prevention and treatment programs for children with parents struggling with substance use disorders.

House Energy and Commerce Committee approves PDMP authorization bill with language to help promote collaboration with State substance abuse agencies
On Thursday July 23, the House Energy and Commerce Committee considered and approved H.R. 1725, the National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2015. The author of the bill is Representative Ed Whitfield (R-KY) and co-sponsors include Representatives Kennedy (D-MA), Buscon (R-IN), and Pallone (D-N.J.). The Chairman of the House Energy and Commerce Subcommittee on Health is Joe Pitts (R-PA) and the Ranking Member of the Subcommittee is Gene Green (D-TX). The bill seeks to continue the momentum gained by States on issues related to data interoperability by requiring applicants for NASPER funds to include certain information in their application. For example, H.R. 1725 requires applicants to report the extent to which the PDMP program is able to share information with other health IT systems such as e-prescribing systems, health information exchanges, and electronic health records systems.

Coordination with NASADAD members: The NASPER Reauthorization Act of 2015, under Section (h), the “Education and Access to the Monitoring Section,” requires States receiving NASPER funding to “…facilitate linkage to the State substance abuse agency and substance use disorder services.” Additional language regarding State substance abuse agencies is included in a section requiring the release of a federal report not later than three years after federal funds are first appropriated under NASPER. This report, among other issues, must include an analysis of the “…extent to which the operation of controlled substance monitoring programs have reduced inappropriate use, abuse, or diversion of controlled substances, established or strengthened initiatives to ensure linkages to substance use disorder services,” and other matters.

Opening statements note importance of addressing opioid issue: In opening statements, a number of Subcommittee members commented on the impact of the opioid issue in their districts. Rep. Whitfield, for example, noted how work to reauthorize NASPER has been moving forward for a number of years.  He also noted that other programs that help support PDMPs are housed in the Department of Justice (DOJ) and Centers for Disease Control and Prevention (CDC). He expressed his hope that work could be done to help coordinate these efforts. Representatives Upton, Pallone, and Pitts echoed their own concerns with the opioid issue and the need for action. Rep. Kennedy dedicated his time to telling a story that seems representative of thousands of others across the country where the use of opioid pain relievers leads to addiction, overdose, and ultimately death.

House Energy and Commerce Subcommittee Committee considers and approves H.R. 1462, the Protecting Our Infants Act
On Thursday, July 23, the House Energy and Commerce Subcommittee on Health considered and approved H.R. 1426, the Protecting Our Infants Act authored by Representatives Katherine Clark (D-MA) and Steve Stivers (R-OH). The author in the Senate is Majority Leader Mitch McConnell (R-KY). The bill would authorize the Secretary of the Department of Health and Human Services (HHS), through the Agency for Healthcare Research and Quality (AHRQ) to conduct a study and develop recommendations for preventing and treating prenatal opioid abuse and NAS. The bill would also authorize the Secretary of HHS to lead a review of planning and coordination efforts across HHS. Finally, the legislation would require the Centers for Disease Control and Prevention (CDC) to offer technical assistance to States to improve the availability and quality of data related to NAS.

View a NASADAD two pager on the Protecting Our Infants act here.

View a NASADAD two pager on NAS here.

View NASADAD’s statement on the Use of Medications for substance use disorders here.

Next Steps for Both Bills
The full Energy and Commerce Committee is expected to consider both bills. This could take place as early as next week. The Chairman of the Full Energy and Commerce Committee is Fred Upton (R-MI) and the Ranking Member is Frank Pallone (D-N.J.).

Additional Resources

To see the Committee’s background memo on the bills, please visit here.

To see the opening statement by Rep. Pitts, please visit here.

To see the opening statement by Rep. Upton, please visit here.

Should you have any questions, or require additional information, please do not hesitate to contact Robert Morrison, Executive Director, (202) 293-0090 or Colleen Haller, Public Policy Associate, at (202) 293-0090.

D.C. Update – July 20, 2015

News from the States

  • Mark Stringer (NASADAD Immediate Past President, MO) appointed new Director for the Missouri Department of Mental Health

Around the Agencies

  • SAMHSA report finds gaps in mental health and substance use disorder treatment among minorities and people without health insurance
  • SAMHSA report finds consistent decline in underage drinking from 2002 to 2013
  • VA and DoD develop continuing education course for health care professionals working with veterans

In the News

  • White House releases new fact sheet on enhancing the fairness and effectiveness of the criminal justice system
  • New National Academies of Sciences, Engineering, and Medicine report suggests new psychosocial interventions for people with mental health and substance use disorders
  • ONDCP Director Michael Botticelli publishes blog post about Conner Adams, a young woman in recovery
  • Center for Substance Abuse Research publishes study finding national treatment admissions for heroin at highest recorded level

Upcoming Events

  • SAMHSA’s Center for Integrated Health Solutions announces webinar on trauma-informed care
  • Congressional Addiction Forum focusing on veterans’ treatment announced for July 29th
  • The National SBIRT ATTC announces new webinar on the relationship between LGBTQ populations and substance use

News from the States

Mark Stringer (NASADAD Immediate Past President, MO) appointed new Director for the Missouri Department of Mental Health
Former NASADAD president Mark Stringer began his new job as Director of the Missouri Department of Mental Health this past week. Stringer previously worked for eight years as the Director of the Division of Behavioral Health, in addition to more than 28 years of experience in the mental health field. Speaking in an interview with the Mid-Missouri public radio station KBIA, Mr. Stringer states that his priorities as Director include building a new State hospital, developing a proper treatment model for people with developmental disabilities and serious mental illness, and securing additional funding for mental health and substance use disorder treatment programs to ensure all Missouri residents have access to treatment. Mr. Stringer is excited to begin his work as Director by visiting State hospitals, rehabilitation centers, and contracted agencies to better understand the full scope of his post.

Around the Agencies

SAMHSA report finds gaps in mental health and substance use disorder treatment among minorities and people without health insurance
A new Substance Abuse and Mental Health Services Administration (SAMHSA) report has found mental health and substance use disorder treatment gaps among minority populations and individuals without health insurance. The “Behavioral Health Equity Barometers” tracks the mental health and substance use disorder treatment of youth and adults by demographics and insurance status on an annual basis. This year’s report found that “approximately 41.6 percent of White adolescents received treatment for depression in the past year, while only 36.9 percent of Hispanic or Latino adolescents and 28.6 percent of Black adolescents received similar treatment.” The report further states that adults without health insurance were more likely to have a dependence on alcohol than those adults with insurance (9.7 percent versus 6.0 percent). Adults without insurance were also significantly less likely to receive proper mental health treatment.

SAMHSA report finds consistent decline in underage drinking from 2002 to 2013
The Substance Abuse and Mental Health Services Administration (SAMHSA) released a new report this past week finding a steady decline in underage drinking from 2002 to 2013. Although alcohol remains the most commonly used substance among adolescents aged 12 to 20, underage drinking among this population decreased from 28.8 percent in 2002 to 22.7 percent in 2013. Youth binge drinking rates similarly declined throughout this period, declining from 19.3 percent in 2002 to 14.2 percent in 2013. The report credits increased parental involvement and national prevention efforts for the observed decreases in underage drinking, yet notes that much work remains to be done.

VA and DoD develop continuing education course for health care professionals working with veterans
The United States Department of Veteran Affairs (VA) and Department of Defense (DoD) developed a new online continuing education course titled “Military Culture: Core Competencies for Health Care Professionals.” The free course aims to help health care professionals better understand the military experiences of veteran patients in order to provide more effective treatment. The course is part of the larger Veterans Choice Program’s effort to increase the quality of health care for veterans across the country.

In the News

White House releases new fact sheet on enhancing the fairness and effectiveness of the criminal justice system
The White House released a new fact sheet on enhancing the fairness and effectiveness of the criminal justice system this past week. The fact sheet compiles a list of policy proposals President Obama recently announced – including sentencing reforms, the re-integration of prisoners post-incarceration into society, community trust in local law enforcement, and juvenile justice. The White House states that “unwarranted disparities and unduly harsh sentences undermine trust in the rule of law and offend the basic principles of fairness and justice.” The Obama Administration hopes that Congress will act on the proposals outlined in this fact sheet to create broad, structural criminal justice reform.

New National Academies of Sciences, Engineering, and Medicine report suggests new psychosocial interventions for people with mental health and substance use disorders
A new report from the National Academies of Sciences, Engineering, and Medicine suggests a new framework for psychosocial interventions in clinical practices for individuals with mental health or substance use disorders. The report suggests that the Department of Health and Human Services (HHS) adopt the outlined framework in order to ensure a consistently high level of care for patients. The framework notes that while many providers are aware of best intervention practices, these practices are rarely utilized in treatment. The National Academies of Sciences, Engineering, and Medicine hopes the framework outlined in the report will help bridge this treatment gap.

ONDCP Director Michael Botticelli publishes blog post about Conner Adams, a young woman in recovery
The Office of National Drug Control Policy (ONDCP) Director Michael Botticelli published a blog post on the White House this week regarding a correspondence between Conner Adams, a young woman in recovery, and President Barack Obama. Botticelli published the post in the wake of President Obama’s commuting of 46 sentences of prisoners convicted of non-violent crimes. The blog post features the letter Conner Adams wrote to President Obama about her own path towards recovery. Adams writes of the importance of second chances and access to treatment, noting the importance that proper treatment had in helping her establish a successful life. President Obama praises Ms. Adams’ progress in his response, stating that her experience is an example of the effect treatment programs can have. The Obama Administration remains committed to advocating for evidence-based solutions that recognize substance use disorders as a medical condition rather than a moral failing.

Center for Substance Abuse Research publishes study finding national treatment admissions for heroin at highest recorded level
The Center for Substance Abuse Research published a new study this past week finding national treatment admissions for heroin at their highest recorded level. The report states that “the percentage of admissions to State-funded substance use disorder treatment facilities citing heroin as a primary substance of abuse has reached the highest level since data collection began in 1992, according to the national Treatment Episode Data Set (TEDS).” Heroin admissions increased to 16% in 2012 from 14% in 2010, while admissions for other opiates remained at 9.7% in 2012 compared to 10.1% in 2011.

Upcoming Events

SAMHSA’s Center for Integrated Health Solutions announces webinar on trauma-informed care
The Substance Abuse and Mental Health Services Administration (SAMHSA)’s Center for Integrated Health Solutions (CIHS) announced a new webinar on trauma-informed care to be held on Wednesday July 29th from 2-3:30 PM EST. The webinar will focus on methods for integrating trauma-informed approaches into primary care clinic practices. SAMHSA notes that trauma-informed care has the potential to improve patient engagement with health care providers to create better health outcomes. Simple steps that all clinics can take to become trauma-informed will be discussed throughout the webinar.

 

Congressional Addiction Forum focusing on veterans’ treatment announced for July 29th
The next installment of the Congressional Addiction Forum – Advancing Treatment and Recovery for Veterans and Servicemembers – has been announced for Wednesday July 29th from 2-4 PM EST. The forum will be hosted by the Addiction Policy Forum, and will feature discussion from stakeholders and policy makers involved in the veteran substance use disorder treatment process. Honorary co-hosts include Senator Sheldon Whitehouse (D-RI), Senator Rob Portman (R-OH), Senator Amy Klobuchar (D-MN), Senator Kelly Ayotte (R-NH), Senator Tammy Baldwin (D-WI), Senator Shelley Moore Capito (R-WV), Congressman Tim Ryan (D-OH), Congressman Steve Chabot (R-OH), Congressman Hal Rogers (R-KY), Congresswoman Tammy Duckworth (D-IL), Congressman Doug Collins (R-GA), and Congresswoman Anne Kuster (D-NH). The forum will be livestreamed over the internet.

The National SBIRT ATTC announces new webinar on the relationship between LGBTQ populations and substance use
The National SBRIT ATTC has announced a new webinar to be held on Wednesday, July 22 from 3-4 PM EST discussing the relationship between lesbian, gay, bisexual, and transgender (LGBTQ) populations and substance use. The webinar will examine the social geography of substance use among LGBTQ individuals, and address the ways substance use may relate to larger health disparities. SAMHSA studies suggest that LGBTQ populations use substances at higher rates than the general population yet enter treatment less frequently.

Should you have any questions, or require additional information, please do not hesitate to contact Robert Morrison, Executive Director, (202) 293-0090 or Colleen Haller, Public Policy Associate, at (202) 293-0090.

D.C. Update – July 13th, 2015

News from NASADAD

  • NASADAD attends AAAS briefing on substance use disorders and incarceration

Around the Agencies

  • Veterans Health Administration releases videos on the safe administration of naloxone
  • CMS releases new infographic outlining five key steps for health care providers transitioning to ICD-10
  • CDC releases new date showing increased heroin usage rates over the past 10 years
  • New AHRQ report states that nearly one in three hospital stays in 2012 involved at least one mental or substance use disorder diagnosis
  • Proposed CMS regulations for Medicare managed care seeks to alter the IMD exclusion

In the News

  • Former Ohio Department of Alcohol and Drug Addiction Services Director Luceille Fleming passes away at age 91
  • Alliance for Health releases new toolkit on telemedicine
  • President Obama nominates Andy Slavitt for CMS administrator

Upcoming Events

  • SAMHSA announces webinar discussing 42 CFR Part 2, the federal regulation governing drug and alcohol use treatment and prevention record confidentiality

News from NASADAD

NASADAD attends AAAS briefing on substance use disorders and incarceration
Brian Denten, Public Policy Intern, attended the briefing hosted by the American Association for the Advancement of Science (AAAS). Two prominent researchers concentrating on the science of substance use disorders spoke at the briefing, noting the high success rates of medication-assisted treatment (MAT) in treating individuals with substance use disorders. Both speakers spoke at length on the effect that substance use disorders have on the brain, suggesting that a combination of MAT and cognitive therapy is the best combination for successful treatment. Methadone, buprenorphine, and Vivitrol were all discussed as potential medication options for individuals struggling with opioid use disorders. The speakers recommended that the criminal justice system increase its effort to create substance use disorder treatment programs for individuals while they are incarcerated to prevent relapse among individuals exiting prison.

Speakers:

  • Charles O’Brien, PhD; Vice-Chair of Pyschiatry at University of Pennsylvania and Director of the Prestigious Center for Studies in Addiction
  • Joshua Lee, PhD; Assistant Professor in Medicine and Psychiatry at New York University Langone Medical Center
  • Remarks: Representative Chaka Fattah (D-PA)

Around the Agencies

Veterans Health Administration releases videos on the safe administration of naloxone
The Department of Veterans Affairs, (VA) Veterans Health Administration released a new series of videos on the safe administration of naloxone. The series is available on YouTube, and describes the signs and symptoms of an opioid overdose and the proper method for administrating intranasal and intramuscular naloxone. A separate video displays how naloxone auto-injectors can also be used to reverse opioid-overdoses.

CMS releases new infographic outlining five key steps for health care providers transitioning to ICD-10
The Centers for Medicare & Medicaid Services (CMS) released a new infographic describing the procedure for health care providers transitioning to the ICD-10 diagnosis codes taking effect on October 1st. The infographic describes five key steps to facilitate a smooth transition process that include staff training, the updating of processes, and the testing of systems. All health care providers covered by the Health Insurance Portability Accountability Act (HIPAA) are required to transition to ICD-10.

CDC releases new data showing increased heroin usage rates over the past ten years
The Centers for Disease Control and Prevention (CDC) released a new edition of the monthly Vital Signs publication this week. This month’s edition concentrates on changing trends and risk factors surrounding heroin use in the United States, finding that in the past ten years “heroin use has more than doubled among people who abused or were dependent on prescription opioid painkillers.” The issue further describes how groups with historically low rates of heroin use – including women, privately insured individuals, and high-income populations – have seen increased rates of heroin use in recent years. The groups at highest risk for heroin use disorders include “non-Hispanic whites, men, 18-to-25 year olds, persons with annual household incomes less than $20,000, people living in urban areas, Medicaid recipients, and the uninsured.” Heroin-related overdose deaths have almost quadrupled in the United States from 2002 to 2013, underlining the importance of determining a comprehensive approach to the heroin epidemic.

New AHRQ report states that nearly one in three hospital stays in 2012 involved at least one mental or substance use disorder diagnosis
A new Agency for Healthcare Research and Quality (AHRQ) report has found that nearly one in three hospital stays in 2012 involved at least one mental health or substance use disorder diagnosis – accounting for 8.6 million patients and 32.3 percent of inpatient stays. About 1.8 million inpatient stays were primarily for mental health or substance use disorders, with mood disorders being the most common mental health diagnosis and alcohol-related disorders being the most common substance use disorder diagnosis. Mental health and substance use disorder inpatient stays were on average longer (6.6 days for mental health and substance use disorders versus 4.8 days for other conditions), yet had lower average costs ($6,300  for mental health and substance use disorders versus $12,600 for other conditions).

Proposed CMS regulations for Medicare managed care seeks to alter the IMD exclusion
The Centers for Medicare and Medicaid Services (CMS) have proposed new rules that would alter the institutions of mental disease (IMD) exclusion. The proposed rules would update the managed care regulations for Medicaid and the Children’s Health Insurance Program (CHIP) to alter the prohibition on using federal Medicaid funding for adult mental health and substance use disorder treatment in institutions of mental disease (residential treatment facilities with more than 16 beds). Under the proposed rules, Medicaid managed care plans would be able to provide funding for adult IMD treatment for up to 15 days. In addition to providing funding for some IMD treatment, the proposed rules would require States to create quality ratings for all Medicaid and Children’s Health Insurance Program (CHIP) managed care plans to ensure plans meet federal standards. NASADAD is working with the Coalition for Whole Health to develop a sign-on letter in support of the proposed rules, along with the suggestion to remove the language limiting IMD stays to only 15 days. Comments are due on July 27, 2015, after which CMS will review the comments received, make changes, and respond with final regulations.

In the News

Former Ohio Department of Alcohol and Drug Addiction Services Director Luceille Fleming passes away at age 91
The former Director of Ohio’s Department of Alcohol and Drug Addiction Services, Luceille Fleming, recently passed away at age 91 following decades of service. Luceille led both Pennsylvania’s and Ohio’s substance use disorder agencies, working under six Governors in two separate States over the course of her career. Her forthright, charismatic leadership helped provide second chances for thousands of men and women. Ohio greatly expanded substance use disorder programs for women and juveniles and established new support groups in prisons – in addition to securing millions of dollars in federal grants for Ohio’s substance use disorder systems during her time as Director. Luceille retired from the Ohio Department of Alcohol and Addiction Services in 2003, receiving numerous State and national awards for her work including the esteemed National Governor’s Distinguished Service Award and induction into the Ohio Women’s Hall of Fame. Ms. Fleming was very active in NASADAD, serving on the NASADAD Board of Directors, including as Board Chair, and participating on the Public Policy Committee, Child Welfare Committee, and much more. Her family suggests donations in her memory be made to the Fleming House in Lisbon, Ohio, or the House of Hope and First Village in Columbus.

Alliance for Health releases new toolkit on telemedicine
Alliance for Health released a new toolkit focusing on the background and future of telemedicine this past week. The toolkit provides an overview of the policy implications and uses of telemedicine, as well as a variety of news articles examining telemedicine in greater detail. Alliance for Health notes that the field of telemedicine has greatly expanded in recent years as more rural and areas take advantage of telemedicine’s lower costs and easier accessibility. The toolkit was produced with support from the Robert Wood Johnson Foundation.

President Obama nominates Andy Slavitt for CMS administrator
President Obama nominated Andy Slavitt for the position of Centers for Medicare and Medicaid Services (CMS) administrator. Slavitt has worked as acting administrator of CMS since March 2015, previously working as an executive at Optum from 2012 to 2014. The former CMS administrator Marilyn Tavenner stepped down from the agency in February following nine years of service. Slavitt will continue to guide CMS through the implementation of the Affordable Care Act, including the issuance of rules on how insurers, pharmaceutical companies, and hospitals should operate under the legislation.

Upcoming Events

SAMHSA announces webinar discussing 42 CFR Part 2, the federal regulation governing drug and alcohol use treatment and prevention record confidentiality
The Substance Abuse and Mental Health Services Administration has announced a new webinar discussing 42 CFR Part 2 to be held on Tuesday, July 21 from 1-2 PM EST. The webinar aims to address and debunk common myths surrounding 42 CFR Part 2 – the federal regulation governing drug and alcohol use treatment and prevention record confidentiality. Several experts will speak on the application of 42 CFR Part 2 and the how adopting electronic health records and health information exchanges affects compliance.

Featured presenters include:

  • Kate Tripping, JD; Public Health Advisor, SAMHSA
  • Deborah Reid, JD; Senior Health Policy Attorney, Legal Action Center
  • Katie O’Neill, JD; Consultant, Legal Action Center

 

Should you have any questions, or require additional information, please do not hesitate to contact Robert Morrison, Executive Director, (202) 293-0090 or Colleen Haller, Public Policy Associate, at (202) 293-0090.

Special DC Update: Appropriations Committees Release Proposed FY 2016 Funding

Download a PDF of this document here.

Status of Proposed FY 2016 Budget and Appropriations for:

Department of Health and Human Services (HHS)

Substance Abuse and Mental Health Services Administration

            Substance Abuse Prevention and Treatment (SAPT) Block Grant

            Center for Substance Abuse Treatment (CSAT)

            Center for Substance Abuse Prevention (CSAP)

            Center for Mental Health Services (CMHS)

Centers for Disease Control and Prevention (CDC)

Health Resources and Services Administration (HRSA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute on Drug Abuse (NIDA)

Department of Justice (DOJ)

  • The “Request” category describes the Administration’s proposed funding level for FY 2016. This is only a proposal.
  • The “House Report” category describes the full House Appropriations Committee’s proposed funding for FY 2016. The House column is labeled in green.
  • The “Senate Report” category describes the full Senate Appropriations Committee’s proposed funding for FY 2016. The Senate column is labeled in red.
  • A final decision regarding FY 2016 funding is not expected until fall.

 

Substance Abuse and Mental Health Services Administration (SAMHSA)

Agency FY 14 FY 15 Enacted FY 16 Request FY 16 House Report FY 15-House FY 16 Change FY 16 Senate Report FY 15-Senate FY 16 Change
SAMHSA $3,621,706,000 $3,621,212,000 $3,665,787,000 $3,642,710,000 $21,498,000 increase $3,460,484,000 $160,728,000 decrease

Substance Abuse Prevention and Treatment (SAPT) Block Grant

Program FY 14 FY 15 Enacted FY 16 Request FY 16 House Report FY 15-House FY 16 Change FY 16 Senate Report FY 15-Senate FY 16 Change
SAPT Block Grant $1,819,856,000 $1,819,856,000 $1,819,856,000 $1,819,856,000 Level funding $1,769,856,000 $50,000,000 decrease

Substance Abuse Prevention and Treatment (SAPT) Block Grant: The House report calls for $1.820 billion for FY 2016, level funding compared to FY 2015. The Senate report calls for $1.770 billion, a decrease of $50 million compared to FY 2015. The Administration also requested level funding.

House Report Language: “The Committee includes bill language directing the Administrator of SAMHSA and the Secretary to exempt the Mental Health Block Grant and the Substance Abuse Prevention and Treatment Block Grant as a source for the PHS evaluation set-aside in fiscal year 2016. The Committee does not include the requested bill language allowing the Administrator to transfer three percent or less of funds between any of the SAMHSA accounts.”

Senate Report Language: “The Committee recommendation continues bill language that instructs the Administrator of SAMHSA and the Secretary to exempt the Mental Health Block Grant (MHBG) and the Substance Abuse Prevention and Treatment (SAPT) Block Grant from being used as a source for the PHS evaluation set-aside in fiscal year 2016, as was done prior to fiscal year 2012.”

“Formula Evaluation—The Committee understands that States are having difficulty interpreting the sources of data used in the current formula for the Substance Abuse Prevention and Treatment Block Grant program. In addition, the formula has not been adjusted since 1997 and is overly confusing. States cannot defend their positions when SAMHSA does not inform them of the origin of the data used for the formula. To increase transparency, the Committee directs SAMHSA to include in their fiscal year 2017 CJ details on where SAMHSA acquires the data used for the formula and how SAMHSA utilizes this information to make funding level determinations. It is imperative that SAMHSA uses the most recent and accurate data available and should work with States to better understand the best sources for this information. SAMHSA shall also include an evaluation on whether the current formula should be updated in the future.”

**Important note about proposed amendment by Senator Patty Murray (D-WA) to restore/add substance use disorder funding – including proposed increase of $50 million for SAPT Block Grant compared to FY 2015: As this report indicates, the Senate Appropriations Committee approved a proposal to cut the SAPT Block Grant by $50 million and reduce other important programs due to stringent spending caps set by sequestration and other factors. Senator Patty Murray, the “Ranking Member” or most senior Democrat on the Committee, offered a lengthy amendment to address the spending caps and restore funding for a number of key public health programs across a number of agencies.

This large amendment included a provision that would have (1) added a total of $100 million to the SAPT Block Grant (restoring the proposed cut by the Senate Committee and adding $50 million compared to FY 2015) and (2) added $50 million for the program supporting opioid treatment where medication assisted treatment is an allowable use of funds. Ultimately, the amendment was not adopted. However, this was an important development demonstrating strong support for the SAPT Block Grant and treatment/prevention/recovery services supported by SAMHSA. Further, this action recognized the intensity of the opioid problem across the country that would benefit from dedicated federal funding. NASADAD will provide updates on this specific provision as developments move forward.

[back to top]

SAMHSA: Center for Substance Abuse Treatment – Appropriations by Program

Program FY 14 FY 15 Enacted FY 16 Request FY 16 House Report FY 15-House FY16 Change FY 16 Senate Report FY 15-Senate FY 16 Change
CSAT TOTAL $360,698,000 $361,463,000 $320,701,000 $377,000,000 $15,537,000 increase $284,260,000 $77,203,000 decrease
Access to Recovery $50,000,000 $38,223,000 $0 $38,223,000 Level funding $0 $38,223,000 decrease
Addiction Technology Transfer Centers (ATTCs) $9,046,000 $9,046,000 $8,081,000 $9,046,000 Level funding $8,081,000 $965,000 decrease
Children and Families $29,678,000 $29,605,000 $29,605,000 $29,605,000 Level funding $28,125,000 $1,480,000 decrease
Criminal Justice Activities $75,000,000 $78,000,000 $61,946,000 $78,000,000 Level funding $61,946,000 $16,054,000 decrease
Crisis Systems N/A N/A $5,000,000 Not funded N/A Not funded N/A
Minority AIDS $65,732,000 $65,570,000 $58,859,000 $65,570,000 Level funding $58,859,000 $6,711,000 decrease
Opioid Treatment Programs/Regulatory Activities $8,746,000 $8,724,000 $8,724,000 $8,724,000 Level funding $8,724,000 Level funding
Pregnant and Postpartum Women $15,970,000 $15,931,000 $15,931,000 $15,931,000 Level funding $15,134,000 $797,000 decrease
Primary Care and Addiction Services Integration N/A N/A $20,000,000 Not funded N/A Not funded N/A
Recovery Community Services Program $2,440,000 $2,434,000 $2,434,000 $2,434,000 Level funding $2,312,000 $122,000 decrease
Screening, Brief Intervention, Referral, and Treatment (SBIRT) $47,000,000 $44,889,000 $30,000,000 $46,889,000 $2,000,000 increase $30,000,000 $14,889,000 decrease
Special Initiatives/Outreach $1,436,000 $1,432,000 $1,432,000 $1,432,000 Level funding $0 Program eliminated
Strengthening Treatment Access and Retention $1,668,000 $1,000,000 $1,000,000 $1,000,000 Level funding $0 Program eliminated
Targeted Capacity Expansion (TCE) General $13,256,000 $23,223,000 $36,303,000 $36,303,000 $13,080,000 increase $29,223,000 $6,000,000 increase
Medication-Assisted Treatment for Prescription Drug and Opioid Addiction N/A $12,000,000 $25,000,000 $25,080,000 $13,080,000 increase $18,000,000 $6,000,000 increase
Treatment Systems for Homeless $41,488,000 $41,386,000 $41,386,000 $41,304,000 $82,000 decrease $39,317,000 $2,069,000 decrease

Center for Substance Abuse Treatment (CSAT): The House report calls for $377 million for FY 2016 or an increase of $15.5 million as compared to FY 2015. The Senate report calls for $284 million or a decrease of $77 million compared to FY 2015. The Administration requested a $40.8 million decrease compared to FY 2015.

Senate Report Language: “Combatting Opioid Abuse—Of the amount provided for Targeted Capacity Expansion, the Committee recommendation includes $18,000,000 for discretionary grants to States for the purpose of expanding treatment services to those with heroin or opioid dependence. The Committee directs CSAT to ensure that these grants include as an allowable use the support of medication assisted treatment and other clinically appropriate services. These grants should target States with the highest rates of admissions and that have demonstrated a dramatic increase in admissions for the treatment of opioid use disorders.”

Access to Recovery (ATR): The House report calls for $38.2 million for FY 2016 or level funding compared to FY 2015. The Senate report does not provide ATR funding for FY 2016. This is consistent with the Administration’s proposal to eliminate the ATR program in FY 2016.

Addiction Technology Transfer Centers: The House report calls for $9 million for FY 2016 or level funding compared to FY 2015. The Senate report calls for $8.1 million or a decrease of $965,000 compared to FY 2015. The Administration also requested a decrease of $965,000 compared to FY 2015.

House Report Language: “The Committee once again rejects the Administration’s request to reduce funding for the ATTCs. SAMHSA is directed to ensure that ATTCs maintain a primary focus on addiction treatment and recovery services.”

Senate Report Language: “The Committee continues to direct SAMHSA to ensure that ATTCs maintain a primary focus on addiction treatment and recovery services.”

Criminal Justice Activities: The House report calls for $78 million for FY 2016 or level funding compared to FY 2015. The Senate report calls for $61.9 million for FY 2015, or a cut of $16 million compared to FY 2015. The Administration also requested a decrease of $16 million compared to FY 2015.

House Report Language: “Drug Treatment Courts—The Committee continues to direct SAMSHA to ensure that all funding appropriated for Drug Treatment courts is allocated to serve people diagnosed with a substance use disorder as their primary condition. SAMHSA is directed to ensure that all drug treatment court grant recipients work directly with the corresponding State substance abuse agency in the planning, implementation, and evaluation of the grant. The Committee further directs SAMHSA to expand training and technical assistance to drug treatment court grant recipients to ensure evidence-based practices are fully implemented.”

Senate Report Language: “The Committee continues to direct SAMHSA to ensure that all funding appropriated for Drug Treatment Courts is allocated to serve people diagnosed with a substance use disorder as their primary condition. The Committee expects CSAT to ensure that non-State substance abuse agency applicants for any drug treatment court grant in its portfolio continue to demonstrate extensive evidence of working directly and extensively with the corresponding State substance abuse agency in the planning, implementation, and evaluation of the grant.”

Minority AIDS Initiative: The House report calls for $65.6 million for FY 2016 or level funding compared to FY 2015. The Senate report calls for $58.9 million for FY 2015, a decrease of $6.7 million compared to FY 2015. The Administration requested a decrease of $6.7 million compared to FY 2015.

Opioid Treatment Programs/Regulatory Activities: The House report calls for $8.7 million for FY 2016, level funding compared to FY 2015. The Senate report calls for $8.7 million for FY 2016, level funding compared to FY 2015. The Administration also requested level funding.

Pregnant and Postpartum Women: The House report calls for $15.9 million for FY 2016, level funding compared to FY 2015. The Senate report calls for $15.1 million for FY 2015, a decrease of $797,000 compared to FY 2015. The Administration requested level funding.

Recovery Community Services Program: The House report calls for $2.4 million for FY 2016, level funding compared to FY 2015. The Senate report calls for $2.3 million for FY 2016, a decrease of $122,000 compared to FY 2015. The Administration requested level funding.

Screening, Brief Intervention, Referral, and Treatment (SBIRT): The House report calls for $46.9 million for FY 2016, or an increase of $2 million as compared to FY 2015. The Senate report calls for $30 million for FY 2016, a decrease of $14.9 million compared to FY 2016. The Administration requested a cut of $14.9 million compared to FY 2015.

Senate Report Language: “The Committee continues to direct SAMHSA to ensure that funds provided for SBIRT are used for existing evidence-based models of providing early intervention and treatment services to those at risk of developing substance abuse disorders.”

Strengthening Treatment Access and Retention: The House report calls for $1 million for FY 2016, or level funding compared to FY 2015. The Senate report does not provide funding for this program in FY 2016. The Administration requested level funding.

Targeted Capacity Expansion (TCE) General Program: The House report calls for $36.3 million for FY 2016, an increase of roughly $13 million compared to FY 2015. The Senate report calls for $29.2 million for FY 2016, an increase of $6 million compared to FY 2015. The Administration requested a $13 million increase to build on a grant program created in FY 2015 with $12 million for CSAT for grants to expand opioid treatment services – including medication-assisted treatment (MAT).

House Report Language: “Together with the $12,000,000 increase provided in the Consolidated and Further Continuing Appropriations Act of fiscal year 2015, this additional funding is provided to increase the number of States from 11 to 22 that are receiving funding to expand services that address prescription drug abuse and heroin use in high-risk communities. The Committee expects SAMSHA to provide a briefing within 45 days of enactment regarding how it intends to execute these activities and carry out the two mandates described below.

The United States has seen a 500 percent increase in admissions to treatment for prescription drug abuse since 2000. Moreover, according to a recent study, 28 states saw an increase in admissions to treatment for heroin dependence during the past two years. The fiscal year 2015 Consolidated and Further Continuing Appropriations Act provided funding for Targeted Capacity Expansion specifically for prescription drug and heroin treatment. The Center for Substance Abuse Treatment is directed to include as an allowable use medication-assisted treatment and other clinically appropriate services to achieve and maintain abstinence from all opioids and heroin and prioritize treatment regimens that are less susceptible to diversion for illicit purposes.

Since the passage of the Drug Addiction Treatment Act of 2000, SAMHSA has led the nation in educating physicians, patients, and treatment systems on the use of medication-assisted treatment. To keep pace with advancements in science and research, SAMHSA is directed to update all of its public-facing information and treatment locators such that all evidence-based innovations in counseling, recovery support, and abstinence-based relapse prevention medication-assisted treatment are fully incorporated.”

Senate Report Language: “Combating Opioid Abuse.-Of the amount provided for Targeted Capacity Expansion, the Committee recommendation includes $18,000,000 for discretionary grants to States for the purpose of expanding treatment services to those with heroin or opioid dependence. The Committee directs CSAT to ensure that these grants include as an allowable use the support of medication assisted treatment and other clinically appropriate services. These grants should target States with the highest rates of admissions and that have demonstrated a dramatic increase in admissions for the treatment of opioid use disorders.”

Treatment Systems for the Homeless: The House report calls for $41.3 million for FY 2016, a slight decrease in funding compared to FY 2015. The Senate report calls for $39.3 million for FY 2016, a $2.1 million decrease compared to FY 2015. The Administration requested level funding.

[back to top]

SAMHSA: Center for Substance Abuse Prevention – Appropriations by Program

Program FY 14 FY 15 Enacted FY 16 Request FY 16 House Report FY 15-House FY 16 Change FY 16 Senate Report FY 15-Senate FY 16 Change
CSAP TOTAL $175,129,000 $175,148,000 $210,918,000 $190,219,000 $15,071,000 increase $182,731,000 $7,583,000 increase
Center for the Application of Prevention Technologies (CAPT) $7,511,000 $7,493,000 $7,493,000 $7,493,000 Level funding $7,119,000 $374,000 decrease
Fetal Alcohol Spectrum Disorder Center for Excellence $1,000,000 $1,000,000 $1,000,000 $1,000,000 Level funding $0 Program eliminated
Grants to Prevent Prescription Drug/Opioid Overdose Related Deaths N/A N/A $12,000,000 Not funded N/A $6,000,000 New program
Federal Drug-Free Workplace Program (formerly Mandatory Drug Testing) $4,906,000 $4,894,000 $4,894,000 $4,894,000 Level funding $4,894,000 Level funding
Minority AIDS $41,307,000 $41,205,000 $41,205,000 $41,205,000 Level funding $39,145,000 $2,060,000 decrease
Science and Service Program Coordination $4,082,000 $4,072,000 $4,072,000 $4,072,000 Level funding $3,868,000 $204,000 decrease
Sober Truth on Preventing Underage Drinking (STOP Act) $7,000,000 $7,000,000 $7,000,000 $7,000,000 Level funding $6,650,000 $350,000 decrease
Strategic Prevention Framework/Partnerships for Success $109,754,000 $109,484,000 $118,254,000 $109,484,000 Level funding $114,984,000 $5,500,000 increase
Strategic Prevention Framework Rx N/A N/A $10,000,000 Not funded N/A $5,500,000 New program
Tribal Behavioral Health Grants N/A N/A $15,000,000 $15,000,000 New program Not funded N/A

Center for Substance Abuse Prevention (CSAP): The House report calls for $190.2 million in FY 2016, a $15.1 million increase from FY 2015. The Senate report calls for $182.7 million for FY 2016, an increase of $7.6 million compared to FY 2015. The Administration requested a $35.8 million increase over FY 2015.

Senate Report Language: “Combatting Opioid Abuse—The Committee provides $6,000,000 for grants to prevention opioid overdose related deaths. As part of the new initiative to Combat Opioid Abuse, this new program will help States equip and train first responders with the use of devises that rapidly reverse the effects of opioids. The Committee directs SAMHSA to ensure applicants outline how proposed activities in the grant would work with treatment and recovery communities in addition to first responders. Furthermore, the Committee provides $5,500,000 for the Strategic Prevention Framework Rx program to increase awareness of opioid abuse and misuse in communities.”

Center for the Application of Prevention Technologies: The House report calls for $7.5 million for FY 2016, level funding compared to FY 2015. The Senate report calls for $7.1 million for FY 2016, a decrease of $374,000 compared to FY 2015. The Administration requested level funding.

Federal Drug-Free Workplace Program (formerly Mandatory Drug Testing): The House report calls for $4.9 million for FY 2016, level funding compared to FY 2015. The Senate report calls for $4.9 million for FY 2016, level funding compared to FY 2015. The Administration also requested level funding.

Fetal Alcohol Spectrum Disorder (FASD) Center of Excellence: The House report calls for $1 million for FY 2016, level funding compared to FY 2015. The Senate report does not provide funding for the FASD Center of Excellence. The Administration requested level funding. The FASD portfolio absorbed a significant cut of $8.8 million in FY 2014 when the program went from $9.8 million in FY 2013 to $1 million in FY 2014.

Minority AIDS Initiative: The House report calls for $41.2 million for FY 2016, level funding compared to FY 2015. The Senate report calls for $39.1 million for FY 2016, a decrease of $2.1 million compared to FY 2015. The Administration requested level funding.

Science and Service Program Coordination: The House report calls for $4.1 million for FY 2016, level funding compared to FY 2015. The Senate report calls for $3.9 million for FY 2016, a decrease of $204,000 compared to FY 2015. The Administration requested level funding.

Sober Truth on Prevention Underage Drinking (STOP) Act: The House report calls for $7 million for FY 2016, level funding compared to FY 2015. The Senate report calls for $6.7 million for FY 2016, a decrease of $350,000 compared to FY 2015. The Administration requested level funding.

Senate Report Language: “The Committee directs that all funds appropriated for STOP Act community-based coalition enhancement grants, shall be used for making grants to eligible communities, and not for other purposes or activities.”

Strategic Prevention Framework/Partnerships for Success: The House report calls for $109.5 million for FY 2016, level funding as compared to FY 2015. The Senate report calls for $115 million for FY 2016, an increase of $5.5 million compared to FY 2015. The Administration requested $118.3 million for FY 2016, an $8.8 million increase in funding from FY 2015.

Senate Report Language: “The Committee intends that these two programs continue to focus exclusively on: addressing State- and community-level indicators of alcohol, tobacco, and drug use; targeting and implementing appropriate universal prevention strategies; building infrastructure and capacity; and prevention substance use and abuse.”

Tribal Behavioral Health Grants: The House report calls for $15 million for this new program in FY 2016. The Senate report does not provide funding for Tribal Behavioral Health Grants. The Administration requested $15 million.

[back to top]

SAMHSA: Center for Mental Health Services – Appropriations by Program

Program FY 14 FY 15 Enacted FY 16 Request HY 16 House Report FY 15-House FY 16 Change FY 16 Senate Report FY 15-Senate FY 16 Change
CMHS TOTAL $377,315,000 $370,538,000 $377,289,000 $383,597,000 $13,059,000 increase $378,597,000 $8,059,000 increase
Children and Family Programs $6,474,000 $6,458,000 $6,458,000 $6,458,000 Level funding $6,458,000 Level funding
Children’s Mental Health $117,315,000 $117,026,000 $117,026,000 $117,026,000 Level funding $117,026,000 Level funding
Community Mental Health Services (CMHS) Block Grant $483,744,000 $482,571,000 $482,571,000 $482,571,000 Level funding $482,571,000 Level funding
Consumer/Consumer Support TA Centers $1,923,000 $1,918,000 $1,918,000 $1,918,000 Level funding $1,918,000 Level funding
Consumer and Family Network Grants $4,966,000 $4,954,000 $4,954,000 $4,954,000 Level funding $4,954,000 Level funding
Criminal and Juvenile Justice Programs $4,280,000 $4,269,000 $4,269,000 $4,269,000 Level funding $4,269,000 Level funding
Crisis Systems N/A N/A $5,000,000 Not funded N/A Not funded N/A
Disaster Response $1,958,000 $1,953,000 $1,953,000 $1,953,000 Level funding $1,953,000 Level funding
Grants for Adult Treatment, Screening, and Brief Response N/A N/A $2,896,000 Not funded N/A Not funded N/A
Grants to States for the Homeless/Prj. for Assist. in Transition from Homelessness $64,794,000 $64,635,000 $64,635,000 $54,635,000 $10,000,000 decrease $40,000,000 $24,635,000 decrease
Healthy Transitions $20,000,000 $19,951,000 $19,951,000 $19,951,000 Level funding $19,951,000 Level funding
HIV/AIDS Education $773,000 $771,000 $771,000 $771,000 Level funding $771,000 Level funding
Homelessness $2,302,000 $2,296,000 $2,296,000 $2,296,000 Level funding $2,296,000 Level funding
Homelessness Prevention Programs $30,772,000 $30,696,000 $30,696,000 $28,696,000 $2,000,000 decrease $30,696,000 Level funding
Mental Health First Aid for Veterans’ Families N/A N/A $4,000,000 Not funded N/A Not funded N/A
MH System Transformation and Health Reform $10,582,000 $3,779,000 $3,779,000 $3,779,000 Level funding $3,779,000 Level funding
Minority AIDS $9,247,000 $9,224,000 $15,935,000 $8,224,000 $1,000,000 decrease $9,224,000 Level funding
National Traumatic Stress Network $46,000,000 $45,887,000 $45,887,000 $45,887,000 Level funding $45,887,000 Level funding
Primary and Behavioral Health Care Integration $50,000,000 $49,877,000 $26,004,000 $43,000,000 $6,877,000 decrease $49,877,000 Level funding
Primary/Behavioral Health Integration TA $1,996,000 $1,991,000 $1,996,000 $1,991,000 Level funding $1,991,000 Level funding
Project AWARE $54,865,000 $54,865,000 $54,865,000 $54,865,000 Level funding $54,865,000 Level funding
Mental Health First Aid $15,000,000 $14,963,000 $14,963,000 $14,963,000 Level funding $14,963,000 Level funding
Project Aware State Grants $40,000,000 $39,902,000 $39,902,000 $39,902,000 Level funding $39,902,000 Level funding
Project LAUNCH $34,640,000 $34,555,000 $34,555,000 $34,555,000 Level funding $34,555,000 Level funding
Protection and Advocacy $36,238,000 $36,146,000 $36,146,000 $36,146,000 Level funding $36,146,000 Level funding
Seclusion & Restraint $1,150,000 $1,147,000 $1,147,000 $1,147,000 Level funding $1,147,000 Level funding
Suicide Prevention $60,032,000 $60,032,000 $62,032,000 $72,725,000 $12,693,000 increase $60,032,000 Level funding
Al/AN Suicide Prevention Initiative $2,938,000 $2,931,000 $2,931,000 $2,931,000 Level funding $2,931,000 Level funding
GLS – Suicide Prevention Resource Center $6,000,000 $5,988,000 $5,988,000 $6,681,000 $693,000 increase $5,988,000 Level funding
GLS – Youth Suicide Prevention – Campus $6,500,000 $6,488,000 $6,488,000 $6,488,000 Level funding $6,488,000 Level funding
GLS – Youth Suicide Prevention – States $35,500,000 $35,427,000 $35,427,000 $47,427,000 $12,000,000 increase $35,427,000 Level funding
National Strategy for Suicide Prevention $2,000,000 $2,000,000 $4,000,000 $2,000,000 Level funding $2,000,000 Level funding
Suicide Lifeline $7,212,000 $7,198,000 $7,198,000 $7,198,000 Level funding $7,198,000 Level funding
Tribal Behavioral Health Grants $5,000,000 $4,988,000 $15,000,000 $15,000,000 $10,012,000 increase $4,988,000 Level funding
Youth Violence Prevention $23,156,000 $23,099,000 $23,099,000 $23,099,000 Level funding $23,099,000 Level funding

Senate Report Language: “Access to Mental Health Services for Veterans—The Committee is aware of the success achieved in localities that use locally customized web portals to assist veterans struggling with mental and substance use issues. These portals provide veterans with a directory of local mental health providers and services in addition to all military and VA funded programs. They also provide quick access to local crisis intervention and emergency care programs; comprehensive job search and support; a peer social networking platform, and personal health records. The Committee encourages SAMHSA to expand and maintain the capacity of locally customized internet-based Web portals nationwide.”

Community Mental Health Services (CMHS) Block Grant: The House report calls for $482.6 million for FY 2016, level funding compared to FY 2015. The Senate report calls for $482.6 million for FY 2016, level funding compared to FY 2015. The Administration also requested level funding.

House Report Language: “The Committee continues the five percent set-aside within the Mental Health Block Grant for evidence-based programs that address the needs of individuals with serious mental illness, including psychotic disorders. The Committee expects SAMHSA to continue its collaboration with the National Institute of Mental Health to encourage States to use this block grant funding to support programs that demonstrate strong evidence of effectiveness.”

Senate Report Language: “The Committee recommendation continues bill language requiring at least 5 percent of the funds for the MHBG program be set-aside for evidence-based programs that address the needs of individuals with early serious mental illness, including psychotic disorders. The Committee commends SAMHSA for its collaboration with NIMH on the implementation of this set-aside. The Committee notes that it usually takes 17 years to translate research findings into practice, and hopes that this joint effort between NIMH and SAMHSA may be a model for how to reduce this timeframe. The Committee directs SAMHSA to continue its collaboration with NIMH to ensure that funds from this set-aside are only used for programs showing strong evidence of effectiveness and targets the first episode of psychosis. SAMHSA shall not expand the use of the set-aside to programs outside of the first episode psychosis. The Committee directs SAMHSA to include in the fiscal year 2017 CJ a detailed table showing at a minimum each State’s allotment, name of the program being implemented, and a short description of the program.”

Criminal and Juvenile Justice Programs: The House report calls for $4.3 million or level funding compared to FY 2015. The Senate report calls for $4.3 million or level funding compared to FY 2015. The Administration also requested level funding.

Grants to States for the Homeless: The House report calls for $54.6 million for FY 2016 or a decrease of $10 million compared to FY 2016. The Senate report calls for $40 million or a decrease of $24.6 million compared to FY 2016. The Administration requested level funding.

Primary and Behavioral Health Care Integration (PBHCI): The House report calls for $43 million for FY 2016 or a decrease of $6.9 million compared to FY 2015. The Senate report calls for $49.9 million or level funding compared to FY 2015. The Administration requested $26 million for FY 2016, a $23.9 million decrease in funding compared to FY 2015.

Suicide Prevention: National Strategy for Suicide Prevention: The House report calls for $2 million for FY 2016 or level funding compared to FY 2015. The Senate report calls for $2 million for FY 2016 or level funding compared to FY 2015. The Administration requested a $2 million increase over FY 2015.

Tribal Behavioral Health Grants: The House report calls for $15 million for FY 2016, or a $10 million increase in funding from FY 2015. The Senate report calls for $5 million or level funding compared to FY 2015. The Administration requested an increase of $10 million.

[back to top]

SAMSHA: Health Surveillance and Program Support – Appropriations by Program

Program FY 14 FY 15 Enacted FY 16 Request FY 16 House Report FY 15-House FY 16 Change FY 16 Senate Report FY 15-Senate FY 16 Change
Behavioral Health Workforce $45,695,000 $46,669,000 $77,669,000 $45,669,000 $1,000,000 decrease $45,669,000 $1,000,000 decrease
Behavioral Health Workforce Data N/A $1,000,000 $1,000,000 $1,000,000 Level funding $1,000,000 Level funding
Health Surveillance $47,428,000 $47,258,000 $49,428,000 $47,258,000 Level funding $44,895,000 $2,363,000 decrease
Performance and Quality Information Systems $12,996,000 $12,918,000 $12,918,000 $12,918,000 Level funding $10,000,000 $2,918,000 decrease
Program Support $72,729,000 $72,002,000 $79,559,000 $72,002,000 Level funding $68,402,000 $3,600,000 decrease
Public Awareness and Support $13,571,000 $13,482,000 $15,571,000 $13,482,000 Level funding $10,000,000 $3,482,000 decrease

Behavioral Health Workforce: The House report calls for $45.7 million for FY 2016 (this amount includes $10,669,000 for the Minority Fellowship Programs), a $1 million decrease compared to FY 2015. The Senate report calls for the same as the House report. The Administration requested a $31 million increase from FY 2015.

House Report Language: “Mental and Behavioral Health Education and Training Program—Within the amount available for Health Surveillance Support, the Committee recommends $35,000,000 for the joint SAMHSA HRSA Mental and Behavioral Health Education and Training Grant Program. Eligible entities for this program shall include accredited programs that train Master’s level social workers, psychologists, counselors, marriage and family therapists, psychology doctoral interns, as well as behavioral health paraprofessionals. The Committee directs SAMHSA to share information concerning pending grant opportunity announcements with State licensing organizations and all the relevant professional associations.”

Senate Report Language: “The Committee is concerned about the uneven distribution of funds among specialties resulting from the initial grant competition in 2014. Therefore, the Committee directs SAMHSA and HRSA to ensure that funding is distributed relatively equally among the participating health professions, including paraprofessionals, master’s level social workers, counselors, marriage and family therapists, and doctoral psychology interns. The Committee directs SAMHSA and HRSA to consider other strategies to achieve this relative distribution such as issuing separate funding opportunity announcements for each participating health profession. In addition, the Committee directs SAMHSA and HRSA to include doctoral psychology schools in the funding opportunities to support doctoral level students completing their practicums which are necessary to move on to internships. SAMHSA and HRSA shall award meritorious applications for doctoral psychology interns first, before doctoral psychology schools applying to support practicums.”

Health Surveillance: The House report calls for $47.3 million for FY 2016, level funding compared to FY 2015. The Senate report calls for $44.9 million for FY 2016, a decrease of $2.4 million compared to FY 2015. The Administration requested a $2.2 million increase from FY 2015.

Public Awareness and Support: The House report calls for $13.5 million for FY 2016, level funding compared to FY 2015. The Senate report calls for $10 million for FY 2016, a decrease of $3.5 million compared to FY 2015. The Administration requested a $2.1 million increase from FY 2015.

[back to top]

Centers for Disease Control and Prevention (CDC) – Appropriations for Selected Programs

Program FY 14 FY 15 Enacted FY 16 Request FY 16 House Report FY 15-House FY 16 Change FY 16 Senate Report FY 15-Senate FY 16 Change
HIV/AIDS, Viral Hepatitis, STD, and TB Prevention $1,120,566,000 $1,117,609,000 $1,161,747,000 $1,117,609,000 Level funding $1,090,609,000 $27,000,000 decrease
HIV Prevention by Health Departments $398,238,000 $397,161,000 $397,161,000 $397,161,000 Level funding $397,161,000 Level funding
School Health $31,161,000 $31,081,000 $37,377,000 $31,081,000 Level funding $31,081,000 Level funding
Viral Hepatitis $31,410,000 $31,331,000 $62,820,000 $31,331,000 Level funding $36,331,000 $5,000,000 increase
Sexually Transmitted Infections $157,719,000 $157,310,000 $157,310,000 $157,310,000 Level funding $125,310,000 $32,000,000 decrease
Chronic Disease Prevention and Health Promotion $1,187,962,000 $1,198,220,000 $1,058,058,000 $1,097,482,000 $100,738,000 decrease $1,052,922,000 $145,298,000 decrease
Tobacco $210,767,000 $215,492,000 $215,492,000 $105,492,000 $110,000,000 decrease $216,492,000 $1,000,000 decrease
Excessive Alcohol Use Not broken out $3,000,000 Not broken out $3,000,000 Level funding $3,000,000 Level funding
Prevention Research Centers $25,530,000 $25,461,000 $25,000,000 $24,000,000 $1,461,000 decrease $25,461,000 Level funding
Community Grants $131,005,000 $130,950,000 $60,000,000 $0 Program eliminated $0 Program eliminated
Birth Defects and Developmental Disabilities $122,435,000 $131,781,000 $131,781,000 $133,510,000 $1,729,000 increase $132,781,000 $1,000,000 increase
Fetal Alcohol Syndrome $10,532,000 $10,505,000 $10,505,000 $11,000,000 $495,000 increase $10,505,000 Level funding
Injury Prevention and Control $150,839,000 $170,447,000 $256,977,000 $211,300,000 $40,853,000 increase $187,947,000 $17,500,000 increase
Unintentional Injury $8,619,000 $8,598,000 $8,598,000 $8,750,000 $152,000 decrease $8,598,000 Level funding
Injury Prevention Activities $29,023,000 $48,950,000 $107,602,000 $98,950,000 $50,000,000 increase $66,450,000 $17,500,000 increase
Prescription Drug Overdose N/A $20,000,000 $68,000,000 $70,000,000 $50,000,000 increase $31,921,000 $11,921,000 increase
Illicit Opioid Use Risk Factors N/A N/A $5,579,000 Not funded N/A $5,579,000 New program
Preventive Health and Health Services Block Grant $160,000,000 $160,000,000 $0 $170,000,000 $10,000,000 increase $160,000,000 Level funding

Tobacco: The House report calls for $105.5 million for FY 2016, a $110 million decrease from FY 2015. The Senate report calls for $216.5 million for FY 2016, a decrease of $1 million from FY 2015. The Administration requested level funding.

House Report Language: “The Committee notes CDC supports tobacco use and prevention activities throughout numerous programs like the Prevention Research Centers and Chronic Disease Prevention activities. The Committee provides funding in the tobacco line to primarily focus on underage smoking. Further, CDC is directed to consolidate and reduce duplication with other tobacco prevention programs and activities. The Committee does not provide support for CDC’s tobacco research activity. The NIH has an existing tobacco research portfolio that in fiscal year 2015 is estimated at $322,000,000. The CDC shall coordinate with NIH to identify meritorious tobacco research opportunities for NIH to consider through its peer-reviewed process and its existing portfolio funding level. The Committee requests an analysis in the fiscal year 2017 budget request identifying all the CDC programs that provide any funding for tobacco control or prevention activities with the name of the program and annual tobacco related funding level.”

Fetal Alcohol Syndrome: The House report calls for $11 million for FY 2016, an increase of $495,000 over FY 2015. The Senate report calls for $10.5 million for FY 2016 or level funding compared to FY 2015. The Administration requested level funding.

House Report Language: “The Committee includes increased resources to support an information clearinghouse, expansion of existing national community-based FAS networks, dissemination of evidence-based intervention strategies, and an Alaska Native/Native American-focused collaborative for FAS.”

Senate Report Language: “Neonatal Abstinence Syndrome Data—The Committee directs CDC to provide technical assistance to States to improve the availability and quality of data collection and surveillance activities regarding neonatal abstinence syndrome, including: (a) the incidence and prevalence of neonatal abstinence syndrome; (b) the identification of causes for neonatal abstinence syndrome, including new and emerging trends; and (c) the demographics and other relevant information associated with neonatal abstinence syndrome. CDC shall also collect any available surveillance data described in the previous sentence from States and make it publicly available on an appropriate website. Furthermore, the Committee directs CDC to increase utilization of effective public health measure to reduce neonatal abstinence syndrome.”

Prescription Drug Overdose Prevention: The House report calls for $70 million for FY 2016, an increase of $50 million over FY 2015. The Senate report calls for $31.9 million for FY 2016, an increase of $11.9 million compared to FY 2015. The Administration requested an increase of $48 million.

House Report Language: “The Committee commends CDC for its leadership to expand the efforts on prescription drug overdose. The Committee directs the CDC Director to implement these activities based on population-adjusted burden of disease criteria when distributing funds for the state Prescription Drug Overdose Prevention activities and to adhere to all terms and conditions identified in the fiscal year statement of managers accompanying the 2015 Appropriations Act and accompanying statement for this program.”

Senate Report Language: “The Committee includes $37,500,000, an increase of $17,500,000 above fiscal year 2015, for efforts to respond to and reverse the opioid epidemic in the United States. This includes $31,921,000 to fund the Prescription Drug Overdose (PDO) Prevention for States program, a competitive cooperative agreement that targets those States with the greatest burden of opioid overdoses and demonstrated readiness to implement prevention strategies, and $5,579,000 to specifically strengthen surveillance efforts for heroin-related deaths. The Committee notes the strong connection between prescription opioids and other types of opioids like heroin. Activities targeting one area will have a significant impact on the other. Therefore, funding will support activities such as implementing guidelines to improve prescribing behaviors and collecting real-time and more accurate data for heroin-related opioid deaths. The Committee urges CDC to require applicants applying for the PDO Prevention for States Program to collaborate with the State substance abuse agency or other agencies or those agencies managing the State’s PDMP to ensure linkages to clinically appropriate substance use disorder services. In addition, the Committee directs CDC to use the funds provided to expand the surveillance of heroin-related deaths beyond CDC’s current activities in HHS’ Region One by targeting States that have the greatest burden of heroin abuse.”

“Opioid Prescribing Guidelines—The Committee directs CDC to complete its work in developing safe opioid prescribing guidelines for chronic, non-cancer pain in outpatient settings for release no later than July 31, 2016, and a technical package to guide States in the implementation of safe opioid prescribing through coordinated care. The guidelines and technical package should include information for providers on the use of opioids for pregnant women and women that might become pregnant, as well as the potential risks of birth defects and neonatal abstinence syndrome from exposure to such medications. The Committee directs CDC to broadly disseminate the guidelines and technical package and to immediately evaluate the effects of the new guidance. Furthermore, the Committee urges CDC to work with the VA and DOD on implementing these guidelines in the appropriate facilities and directs CDC to share data and best practices on safe opioid prescribing with these agencies.”

[back to top]

Health Resources and Services Administration (HRSA) – Appropriations for Selected Programs

Program FY 14 FY 15 Enacted FY 16 Request FY 16 House Report FY 15-House FY 16 Change FY 16 Senate Report FY 15-Senate FY 16 Change
Community Health Centers $1,495,236,000 $1,491,422,000 $1,491,422,000 $1,491,522,000 $100,000 increase $1,419,522,000 $100,000 increase
Interdisciplinary Community-Based Linkages $71,563,000 $73,403,000 $53,153,000 $74,403,000 $1,000,000 increase $74,992,000 $1,589,000 increase
Mental and Behavioral Health $7,916,000 $8,916,000 $8,916,000 $9,916,000 $1,000,000 increase $8,916,000 Level funding
Maternal and Child Health Block Grant $634,000,000 $637,000,000 $637,000,000 $638,200,000 $1,200,000 increase $615,276,000 $21,724,000 decrease
Rural Health $142,335,000 $147,471,000 $127,562,000 $147,471,000 Level funding $150,571,000 $3,100,000 decrease
Rural and Community Access to Emergency Devices $3,364,000 $4,500,000 $0 $4,500,000 Level funding $0 Program eliminated
Telehealth $13,900,000 $14,900,000 $14,900,000 $14,900,000 Level funding $18,000,000 $3,100,000 increase
Ryan White HIV/AIDS Program $2,318,781,000 $2,318,781,000 $2,322,781,000 $2,318,781,000 Level funding $2,293,781,000 $25,000,000 decrease

Mental and Behavioral Health: The House report calls for $9.9 million for FY 2016, an increase of $1 million over FY 2015. The Senate report calls for $8.9 million for FY 2016, level funding compared to FY 2015. The Administration requested level funding.

House Report Language: “The Committee recommendation includes $9,916,000 for the interprofessional Graduate Psychology Education Program to increase the number of health service psychologists (including doctoral-level clinical, counseling and school psychologists) trained to provide integrated services to high-need underserved populations in rural and urban communities. The Committee encourages HRSA to build on recent efforts to expand training to increase mental and behavioral health services for returning service members, veterans and their families, with a strong emphasis on veterans reintegrating into rural civilian communities. Recognizing the growing need for highly trained mental and behavioral health professionals to deliver evidence-based services to the rapidly aging population, the Committee encourages HRSA to invest in geropsychology training programs and to help integrate health service psychology trainees at Federally Qualified Health Centers.”

Maternal and Child Health Block Grant: The House report calls for $638.2 million for FY 2016, an increase of $1.2 million over FY 2015. The Senate report calls for $615.3 million for FY 2016, a decrease of $21.7 million compared to FY 2015. The Administration requested level funding.

House Report Language: “Fetal Alcohol Syndrome—The Committee recommends that the fetal alcohol syndrome initiative within HRSA address high-risk Alaska Native and American Indian populations through a Native American-focused collaborative.”

Rural and Community Access to Emergency Devices: The House report calls for $4.5 million in FY 2016 or level funding compared to FY 2015. The Senate report does not provide funding for this program. The Administration proposed that this program be eliminated in FY 2016. In FY 2015, Congress appropriated a $1.1 million increase over 2014 to be used for opioid overdose reversal emergency devices.

Ryan White HIV/AIDS Program: The House report calls for $2.3 billion for FY 2016 or level funding as compared to FY 2015. The Senate report calls for $2.293 billion for FY 2016, a $25 million decrease compared to FY 2015. The Administration requested a $4 million increase in funding for FY 2016.

[back to top]

National Institute on Alcohol Abuse and Alcoholism (NIAAA) – Appropriations

Program FY 14 FY 15 Enacted FY 16 Request FY 16 House Report FY 15-House FY 16 Change FY 16 Senate Report FY 15-Senate FY 16 Change
NIAAA $446,025,000 $447,408,000 $459,833,000 $456,012,000 $8,604,000 increase $469,355,000 $21,947,000 increase

National Institute on Alcohol Abuse and Alcoholism (NIAAA): The House report calls for $456 million for FY 2016, an increase of $8.6 million compared to FY 2015. The Senate report calls for $469 million for FY 2016, an increase of $21.9 million compared to FY 2015. The Administration requested a $12.4 million increase from FY 2015.

House Report Language: “Fetal Alcohol Syndrome (FAS) Research—The Committee was pleased that NIAAA’s budget request proposed increases in research on how alcohol interferes with human development and the various underlying aspects of alcohol-induced fetal damage. The Committee encourages NIH to consider the benefits and methods to support a clearinghouse and improved coordination with federal and private sector partners to best facilitate the translation of science into public health promotion strategies and interventions benefiting individuals living with FAS.”

Senate Report Language: “Genomic Research and Alcohol Dependence—The Committee commends the NIAAA for its research efforts to increase understanding of the genetic and neurobiological mechanisms underlying alcohol use disorder (AUD). Research shows that genes contribute 40-60 percent of the risk for developing AUD. Factors such as stress may make individuals who carry genomic variations associated with increased risk for AUD more vulnerable to developing the disorder. NIAAA-supported studies have identified several genes that contribute to susceptibility to AUD and many others that show some evidence of involvement; and these research findings are paving the way for new opportunities in prevention and treatment. The Committee encourages the NIAAA to capitalize on advances in genomic science and “big data,” and explore collaborative opportunities to gain additional insight into the genetics of AUD, including its relationship to related problems such as post-traumatic stress disorder in military personnel and veterans.”

National Institute on Drug Abuse (NIDA) – Appropriations

Program FY 14 FY 15 Enacted FY 16 Request FY 16 House Report FY 15-House FY 16 Change FY 16 Senate Report FY 15-Senate FY 16 Change
NIDA $1,025,435,000 $1,028,614,000 $1,047,397,000 $1,050,875,000 $22,261,000 increase $1,069,086,000 $40,472,000 increase

National Institute on Drug Abuse (NIDA): The House report calls for $1.1 billion for FY 2016, an increase of $22.3 million over FY 2015. The Senate report calls for $1.1 billion for FY 2016, and increase of $40 million compared to FY 2015. The Administration requested an $18.8 million increase from FY 2015.

House Report Language: “Adolescent Behavioral and Cognitive Development (ABCD)—The Committee applauds the Collaborative Research on Addictions at NIH initiative and the launch of the ABCD study. Unique in its scope and duration, the study will recruit 10,000 youth before they begin using alcohol, marijuana, nicotine, and other drugs, and follow them over 10 years into early adulthood to assess how substance use affects the trajectory of the developing brain. The Committee commends the study design which will used advanced brain imaging as well as psychological and behavioral research tools to evaluate brain structure and function and track substance use, academic achievement, IQ, cognitive skills, and mental health over time.

Medications Development—The Committee understands NIDA is considering new technologies for the development of next-general pharmaceuticals. For example, NIDA is exploring approaches to develop viable immunotherapeutic or biologic (e.g., bioengineered enzymes) approaches for treating addiction. The Committee looks forward to hearing more about work in this area in the fiscal year 2017 budget request.

NIDAMED—The Committee encourages its support for NIDAMED, an initiative designed to reach out to physicians, physicians in training, and other health care professionals to increase especially those treating our youth to better recognize the signs that lead to drug abuse and addiction.

Opioid Drug Abuse—The Committee remains concerned about prescription drug abuse, specifically the misuse of orally administered opioid drugs. According to some reports, more than 35 million Americans have abused prescription opioids at some point in their lifetimes. The June 2011 Institute of Medicine report on relieving pain indicates that such abuse and misuse resulted in an annual estimated cost to the Nation of $72.5 billion. The Committee expects NIDA to continue to support meritorious scientific activities related to research on medications to alleviate pain with reduced abuse liability and, as appropriate, to work with private partners on innovative research into such medications. In addition, NIDA should continue to fund research to better prevent and treat prescription drug abuse and to coordinate with CDC to help identify scientific research gaps. The Committee requests an update in the fiscal year 2017 budget request on the activities related to addressing the opioid drug abuse problem.”

[back to top]

Department of Justice – Appropriations for Selected Programs

Program FY 14 FY 15 Enacted FY 16 Request FY 16 House Report FY 15-House FY 16 Change FY 16 Senate Report FY 15-Senate FY 16 Change
Drug Enforcement Administration $2,018,000,000 $2,033,320,000 $2,091,609,000 $2,073,945,000 $40,625,000 increase $2,033,320,000 Level funding
Office of Justice Programs $1,503,300,000 $1,537,300,000 $1,649,900,000 $1,015,400,000 $521,900,000 decrease $1,467,800,000 $69,500,000 decrease
Research, Evaluation and Statistics $120,000,000 $111,000,000 $151,900,000 $0 Not explicitly funded $117,000,000 $6,000,000 decrease
State and Local Law Enforcement Assistance $1,171,500,000 $1,241,000,000 $1,142,300,000 $1,015,400,000 $225,600,000 decrease $1,102,000,000 $139,000,000 decrease
Byrne Memorial Justice Assistance Grants $376,000,000 $376,000,000 $388,000,000 $509,000,000 $133,000,000 increase $382,000,000 $6,000,000 increase
Drug Courts $40,500,000 $41,000,000 $36,000,000 $46,000,000 $5,000,000 increase $41,000,000 Level funding
Mentally Ill Offender Act $8,250,000 $8,500,000 $14,000,000 $13,000,000 $4,500,000 increase $10,000,000 $1,500,000 increase
Residential Substance Abuse Treatment (RSAT) $10,000,000 $10,000,000 $14,000,000 $0 Program eliminated $12,000,000 $2,000,000 increase
Second Chance Act/Offender Reentry $67,750,000 $68,000,000 $120,000,000 $68,000,000 Level funding $68,000,000 Level funding
Veterans Treatment Courts $4,000,000 $5,000,000 $4,000,000 $15,500,000 $10,500,000 increase $5,000,000 Level funding
Prescription Drug Monitoring $7,000,000 $11,000,000 $9,000,000 $16,000,000 $5,000,000 increase $7,000,000 $4,000,000 decrease
Juvenile Justice Programs $254,500,000 $251,500,000 $339,400,000 $183,500,000 $68,000,000 decrease $253,500,000 $2,000,000 increase
Community Oriented Policing Systems (COPS) $214,000,000 $208,000,000 $303,500,000 $235,000,000 $27,000,000 increase $212,000,000 $4,000,000 increase
Anti-Methamphetamine Task Forces $7,500,000 $7,000,000 $0 $0 Program eliminated $7,000,000 Level funding
Anti-Heroin Task Forces New line item $7,000,000 $0 $0 Program eliminated $7,000,000 Level funding

Drug Enforcement Administration: The House report calls for $2.1 billion for FY 2016, a $40.6 million increase from FY 2015. The Senate report calls for $2 billion or level funding as compared to FY 2015. The Administration requested an increase of $58.3 million.

Senate Report Language: “Drug Diversion at Veterans Health Administration Facilities – The Committee is alarmed by the rates of prescription drug opioid abuse and related overdoses among veterans, as well as allegations of diversion of prescription opioids from Veterans Health Administration (VHA) facilities into the illicit drug market. The notion that VHA facilities are a source for the unauthorized distribution and use of opioids is extremely concerning. The Committee urges the DEA to maintain open communication with the VHA and treat investigations of drug diversion in VHA facilities as a priority.

Prescription Drug Abuse – The Committee believes that prescription drug abuse continues to remain an urgent public health crisis. Of particular concern is the link between prescription opioid abuse and its connection to heroin use. The Committee urges the DEA to continue to combat prescription drug abuse and heroin use by fully utilizing all available resources, including the Diversion Control Program, and by facilitating inter-agency and inter-department cooperation.”

Byrne Memorial Justice Assistance Grants: The House report calls for $509 million for FY 2016, an increase of $133 million over FY 2015 levels. The Senate report calls for $382 million for FY 2016, a $6 million increase over FY 2015.The Administration requested a $12 million increase.

Senate Report Language: “The Department should expect State, local, and tribal governments to target funding to programs and activities that conform with evidence-based strategic plans developed through broad stakeholder involvement. The Committee directs the Department to make technical assistance available to State, local, and tribal governments for the development or update of such plans.”

Drug Courts: The House report calls for $46 million for FY 2016, an increase of $5 million as compared to FY 2015. The Senate report calls for level funding for FY 2016, or $41 million. The Administration requested a $5 million decrease compared to FY 2015.

House Report Language: “The recommendation includes $41,000,000 for drug courts, which is $5,000,000 above the request. Drug courts help reduce recidivism and substance abuse among non-violent offenders and increase the likelihood of an offender’s successful rehabilitation through intense, judicially supervised treatment, mandatory periodic drug testing, community supervision, and appropriate sanctions according to this addiction treatment in different rehab centers online. The Committee expects these funds to be used to provide grants and technical assistance to State, local, and tribal governments to support the development, expansion, and enhancement of drug courts, based upon their efficacy as a systematic response to substance abuse and crime.”

Prescription Drug Monitoring: The House report calls for $16 million for FY 2016, an increase of $5 million compared to FY 2015. The Senate report calls for $7 million or a $4 million decrease compared to FY 2015.The Administration requested a $2 million decrease for FY 2016.

House Report Language: “The recommendation includes $11,000,000 for the Prescription Drug Monitoring Program (PDMP). The diversion and abuse of prescription medications has become our Nation’s fastest growing drug problem, with overdose deaths now surpassing motor vehicle accidents as the number one cause of accidental deaths nationwide. The Committee maintains its support for the provision of technical assistance for PDMPs, PDMP data users and other key stakeholders through this program. Further, the Committee directs the Bureau of Justice Assistance (BJA) to continue partnerships with other professional organizations that foster interstate interoperability and connectivity among State-run PDMPs, and encourages BJA to continue its support for efforts to establish a national network of interconnected PDMPs. The Committee also supports efforts to increase use of PDMPs among authorized users. The Committee directs BJA to assess the impact of establishing threshold enrollment and utilization rates and, where enrollment and utilization rates are not 100 percent, assess the feasibility of requiring benchmarks for improvements in enrollment and utilization as grant eligibility criteria. The Committee directs the Department to report, not later than 180 days after enactment of this Act, on this assessment, including the potential of prioritizing funding based on the goal of optimizing prescriber and dispenser enrollment and utilization rates for PDMPs by prescriber and dispensers. In the meantime, the Committee directs BJA to prioritize grant funding for States which are engaged in initiatives to integrate PDMP data with electronic health systems, such as electronic health records and electronic prescribing systems.”

Senate Report Language: “The Committee directs the Bureau of Justice Assistance to assess the impact of establishing threshold enrollment and utilization rates for the Prescription Drug Monitoring Program and, where enrollment and utilization rates are below 100 percent, assess the feasibility of requiring benchmarks for improvements in enrollment and utilization as grant eligibility criteria. The Committee directs the Department to report, not later than 180 days after enactment of this act, on this assessment, including the potential of prioritizing funding based on the goal of optimizing prescriber and dispenser enrollment and utilization rates for Prescription Drug Monitoring Programs by prescribers and dispensers as a ratio compared to the potential universe of prescribers and dispensers and controlled substance prescribing rates, respectively.”

Mentally Ill Offender Act: The House report calls for $13 million for FY 2016, an increase of $4.5 million compared to FY 2015. The Senate report calls for $10 million in funding for Mentally Ill Offender Courts (likely referring to Mentally Ill Offender Act), a $1.5 million increase over FY 2015. The Administration requested a $5.5 million increase.

Residential Substance Abuse Treatment (RSAT): The House report does not provide funding for the RSAT program. The Senate report calls for $12 million for FY 2016, or an increase of $2 million over FY 2015.The Administration requested $14 million for FY 2016, a $4 million increase in funding compared to FY 2015.

Second Chance Act/Offender Reentry: The House report calls for $68 million for FY 2016, level funding compared to FY 2015. The Senate report also calls for level funding or $68 million for FY 2016.The Administration requested a $52 million increase.

House Report Language: “The Committee remains concerned that despite a dramatic increase in corrections spending over the past two decades, recidivism and re-incarceration rates are largely unchanged. The Committee is aware that case studies of innovative, evidence-based practices provide a strong indication that this pattern can be reversed. The Committee expects that Second Chance Act grants will foster the implementation of strategies that have been proven to reduce recidivism and ensure safe and successful reentry back to their communities of adults released from prisons and jails. The Committee expects DOJ to designate funds for proven, evidence-based programs that will further the goal of maximizing public safety.”

Senate Report Language: “The SCA supports activities such as employment assistance, substance abuse treatment, housing, mentoring, family programming, and victim support. SCA grants will also support demonstration projects designed to test the impact of new strategies and frameworks…The Department is directed to submit as part of its spending plan for State and Local Law Enforcement Assistance a strategy for the use of all funds appropriated for Second Chance Act programs, including new initiatives requested by the Department that are funded in this recommendation.”

Veterans Treatment Courts: The House report calls for $15.5 million for FY 2016, an increase of $10.5 million compared to FY 2015. The Senate report also calls for level funding or $5 million for FY 2016. The Administration requested a $1 million decrease compared to FY 2016.

House Report Language: “The recommendation includes $5,000,000 to support veterans treatment courts. The Committee expects the Department to work in conjunction with the Department of Veterans Affairs, as appropriate, to provide grant support for collaborative, rehabilitative approaches for continuing judicial supervision over offenders who are veterans. These funds are to be used for court startup and training costs.”

Senate Report Language: “The Committee urges the Department to work in conjunction with the Department of Veterans Affairs to provide grant support for collaborative, rehabilitative approaches for continuing judicial supervision of offenders who are veterans. The Committee recommends not less than $5,000,000 for Veterans Treatment Courts and urges the Department to strengthen funding for existing Veterans Treatment Courts with successful track records to promote best practices.”

[back to top]